Last reviewed · How we verify
L-Boronophenylalanine intravenous administration — Competitive Intelligence Brief
phase 1
Small molecule
Live · refreshed every 30 min
Target snapshot
L-Boronophenylalanine intravenous administration (L-Boronophenylalanine intravenous administration) — Neutron Therapeutics, LLC.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| L-Boronophenylalanine intravenous administration TARGET | L-Boronophenylalanine intravenous administration | Neutron Therapeutics, LLC | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- L-Boronophenylalanine intravenous administration CI watch — RSS
- L-Boronophenylalanine intravenous administration CI watch — Atom
- L-Boronophenylalanine intravenous administration CI watch — JSON
- L-Boronophenylalanine intravenous administration alone — RSS
Cite this brief
Drug Landscape (2026). L-Boronophenylalanine intravenous administration — Competitive Intelligence Brief. https://druglandscape.com/ci/l-boronophenylalanine-intravenous-administration. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab